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AbsTRACT
background The health status and needs of indigenous 
populations of Australia, Canada and New Zealand 
are often compared because of the shared experience 
of colonisation. One enduring impact has been a 
disproportionately high rate of commercial tobacco use 
compared with non-indigenous populations. All three 
countries have ratified the WHO Framework Convention 
on Tobacco Control (FCTC), which acknowledges the 
harm caused to indigenous peoples by tobacco.
Aim and objectives We evaluated and compared 
reporting on FCTC progress related to indigenous 
peoples by Australia, Canada and New Zealand as States 
Parties. The critiqued data included disparities in smoking 
prevalence between indigenous and non-indigenous 
peoples; extent of indigenous participation in tobacco 
control development, implementation and evaluation; 
and what indigenous commercial tobacco reduction 
interventions were delivered and evaluated.
Data sources We searched FCTC: (1) Global Progress 
Reports for information regarding indigenous peoples 
in Australia, Canada and New Zealand; and (2) country-
specific reports from Australia, Canada and New Zealand 
between 2007 and 2016.
study selection Two of the authors independently 
reviewed the FCTC Global and respective Country 
Reports, identifying where indigenous search terms 
appeared.
Data extraction All data associated with the identified 
search terms were extracted, and content analysis was 
applied.
Results It is difficult to determine if or what progress 
has been made to reduce commercial tobacco use by the 
three States Parties as part of their commitments under 
FCTC reporting systems. There is some evidence that 
progress is being made towards reducing indigenous 
commercial tobacco use, including the implementation 
of indigenous-focused initiatives. However, there are 
significant gaps and inconsistencies in reporting. 
Strengthening FCTC reporting instruments to include 
standardised indigenous-specific data will help to realise 
the FCTC Guiding Principles by holding States Parties to 
account and building momentum for reducing the high 
prevalence of commercial tobacco use among indigenous 
peoples.
InTRoDuCTIon
Indigenous peoples experience an alarmingly 
high burden of tobacco-related morbidity and 
mortality.1 2 While some indigenous peoples have 
traditionally used tobacco for ceremonial or sacred 
purposes, it is increasingly recognised that the use 
of commercial tobacco (produced for recreational 
use by for-profit companies using processed leaf 
and chemical additives) is a major factor in indige-
nous health inequities.2–4 
The WHO Framework Convention on Tobacco 
Control (FCTC), which came into force in 2005, is 
an international treaty that recognises the dispro-
portionate harm caused by commercial tobacco to 
indigenous peoples. The FCTC includes a preamble, 
guiding principles and extensive commentary on 
tobacco control measures and associated activi-
ties. The Preamble states that Parties are ‘Deeply 
concerned about the high levels of smoking and 
other forms of tobacco consumption by indige-
nous peoples’ (FCTC, Preamble)2 (p. 2). It also 
acknowledges the evidence for tobacco-related 
harms, the increase of tobacco consumption by 
women and girls, the threat posed by advertising 
and promotion, illicit trade and the need for coop-
erative action to reduce commercial tobacco use.2 
The FCTC requires each Party to submit regular 
reports on progress towards their respective obliga-
tions.2 5 Where practicable, indicators for the afore-
mentioned areas are included within the FCTC 
reporting Core Instrument.
This paper evaluates reporting under the FCTC 
between 2007 and 2016 on commercial tobacco use 
and FCTC progress on tobacco control regarding 
indigenous peoples. As outlined in the FCTC, 
and in alignment with the United Nations Decla-
ration on the Rights of Indigenous Peoples,6 such 
data could document and monitor how indigenous 
peoples have participated in the design, imple-
mentation and evaluation of commercial tobacco 
reduction interventions; providing evaluation 
data on general and indigenous specific interven-
tions for indigenous peoples; and documenting 
commercial tobacco use. The influence of FCTC 
reporting results in various incentives and pressures 
to improve tobacco control, demonstrating tobacco 
control achievements and areas for improvement. 
FCTC reporting recognises Parties’ accountability, 
particularly to indigenous peoples, domestically 
and internationally through their obligations as 
WHO Members. Ultimately, the value of the FCTC 
is whether this leads to better tobacco control, 
reduced commercial tobacco use and consequently 
reduced burden of tobacco related harms to reaf-
firm the right of all people to the highest standard 
of health.2 It is thus timely to consider what FCTC 
progress has been reported to reduce commercial 
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Figure 1 Commercial tobacco use in Australia, Canada and New Zealand by indigenous population and the general population.
tobacco use among indigenous peoples in acceding countries. 
This provides opportunities to reduce commercial tobacco use 
among indigenous peoples, sharing the findings among ratified 
and non-ratified countries.
bACkgRounD
The WHO estimates that tobacco use will cause 8 million deaths 
annually by 2030.7 While many countries have indigenous popu-
lations, Australia, Canada, New Zealand (Aotearoa) and the USA 
are often seen as natural comparators in relation to indigenous 
health. For the purposes of this paper, we have focused on indig-
enous peoples located within three high-income countries with 
ongoing experiences of colonisation: Australia, Canada and New 
Zealand. These countries have ratified the FCTC, while the USA 
has not ratified the FCTC. Thus, the USA cannot be included 
in this study. Furthermore, these countries have similar gross 
national income per capita, political environments, legislative 
frameworks and colonial histories. They also consistently place 
near the top of the United Nations Development Programme’s 
Human Development Index rankings.8 Australia, Canada 
and New Zealand’s colonial histories have limited indigenous 
peoples’ participation in decision making and have indigenous 
populations who experience poorer health outcomes than their 
non-indigenous counterparts.8
Smoking prevalence has declined among the general popula-
tion in many high-income countries, including Australia, Canada 
and New Zealand.9 This includes recent declines in commercial 
tobacco use among indigenous populations in Australia and New 
Zealand.1 10 11 However, the prevalence of commercial tobacco 
use between indigenous and non-indigenous peoples continues 
to be disparate.1 10–12 The prevalence of commercial tobacco use 
(figure 1) in the general population of Australia, Canada and 
New Zealand is 16%, 18% and 16% respectively.10–14 Data 
suggest prevalence of commercial tobacco use among Aboriginal 
and Torres Strait Islander peoples in Australia (41%), First 
Nations (40%), Inuit (49%) and Métis (37%) peoples in Canada 
and Māori peoples in New Zealand (35%)11 is substantially 
higher than their non-indigenous counterparts.
Research suggests that some of the drivers associated with 
commercial tobacco use are similar for indigenous and non-in-
digenous peoples.15 16 For example, socioeconomic status (SES) 
is strongly linked to smoking.17 Indigenous populations overall 
report lower SES, increasing the risk of commercial tobacco use 
and consequently experiencing tobacco-related morbidity and 
mortality.17 For indigenous peoples, lower SES is an outcome 
that has impacted over generations through the mechanics of 
colonisation that have eroded power, social structures and indig-
enous community resources.18–20 The erosion of social structures 
and intergenerational connectedness with associated impacts 
and added stressors resulting from colonisation have directly and 
indirectly impacted commercial tobacco use.15 16 20 21 Commer-
cial tobacco was used as a form of payment, with tobacco issued 
as rations on missions in Australia.22–24 In Canada, ceremonial 
practices such as ceremonial tobacco use were illegal under 
amendments to the Indian Act of 1885, but commercial tobacco 
use was not, which prompted the use of commercial tobacco 
use.20 24
The FCTC recognises the needs and challenges experienced 
by indigenous peoples, and the importance of facilitating indig-
enous leadership and participation in developing, implementing 
and evaluating commercial tobacco reduction interventions.2 
Numerous countries with indigenous populations are Parties to 
the FCTC, including Australia, Canada and New Zealand. Given 
the FCTC indigenous clauses and broader reporting commit-
ments, Parties with indigenous populations could expect the 
need to consistently collect and report: high-quality data that are 
accurate and comprehensively cover areas of commercial tobacco 
use and are comparable across countries to allow comparisons. 
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Table 1 Reference to indigenous or ethnicity in FCTC Global Progress 
Reports by year
Year* Indigenous reference and data
2007 No references, no data in FCTC reports.
2008 No references, no data in FCTC reports.
2009 No references, no data in FCTC reports.
2010 Reference to disparities in smoking prevalence by ethnicity in New Zealand, 
which ranged between 12% and 45% (p. 46). The 45% smoking prevalence 
referred to the Māori daily smoking rate.
2012 References to indigenous peoples for Australia, New Zealand, Ecuador, 
Guatemala and Paraguay, including reporting smoking prevalence 
compared with the general population. Use of the term ‘ethnicity’ was 
recognised as being inconsistently applied across Parties.
2014 References to ‘indigenous’ were limited to Australia in relation to a 
programme for indigenous (Aboriginal and Torres Strait Islander people) 
populations and New Zealand indigenous (Māori) females having 
higher smoking prevalence than males. Use of the term ‘ethnicity’ was 
inconsistently applied across parties.
There was also reference to higher smoking in ‘specific ethnic groups’ in 
Australia, Benin, Italy, Kazakhstan, Lao People’s Democratic Republic, New 
Zealand, Singapore and Spain.
2016 No references to ‘indigenous’ groups.
Thirty-four FCTC parties (26%) indicated they had data for commercial 
tobacco use by ethnic groups.
*Progress reporting moved from annual to biennial after 2010.
FCTC, Framework Convention on Tobacco Control. 
The first FCTC report was compiled in 2007 and covered the 
initial 2-year period after the FCTC was enacted. The WHO 
developed a standard reporting template and a compendium of 
indicators.5 Reports were compiled between 2007 and 2016. 
FCTC reports are available to review as summary Global Prog-
ress Reports across all parties or as individual country reports.5
AIm AnD objeCTIves
This study evaluates FCTC reporting of progress made in rela-
tion to indigenous obligations in Australia, Canada and New 
Zealand. We specifically examined:
1. Whether indigenous data were being reported in relation to 
indigenous peoples, including any disparities between indig-
enous and non-indigenous commercial tobacco use.
2. The extent of indigenous participation in commercial tobac-
co intervention development, implementation and evalua-
tion.
3. If indigenous commercial tobacco reduction interventions 
were being delivered and evaluated under the FCTC.
meThoDs
search strategy
We undertook a two-pronged search of: (1) all Global Progress 
Reports on implementation of the FCTC from its commence-
ment (2007–2016) for information regarding indigenous peoples 
in Australia, Canada and New Zealand, and (2) FCTC coun-
try-specific reports from Australia, Canada and New Zealand.
search terms
To address the study’s aims and identify indigenous-reported 
activities, achievements, innovative approaches and ‘wise prac-
tices’25 (p. 7), we searched each report for ‘Indigenous’ search 
terms (search strategy is available on request). The search terms 
were intended to capture references to indigenous peoples in 
Australia, Canada and New Zealand. To ensure any references 
to indigenous peoples in Canada were identified, the search 
included indigenous terms used throughout North America. This 
included terms used in USA, although it has not ratified the FCTC 
and is not included in this study. The term ‘Ethnic’ was also used 
as a search term due to the FCTC reporting template including 
an 'ethnic' data collection field but not including an indigenous 
specific data collection field. Any references to ‘ethnic’ in the 
results are where it is clearly in reference to indigenous peoples.
Data extraction
Two reviewers (RM and AW) with lived indigenous experience 
and expertise in indigenous commercial tobacco control inde-
pendently reviewed the FCTC Global and Country specific 
reports to identify where search terms appeared.
Data synthesis
We applied conventional content analysis to the extracted data.26 
Two authors (RM and AW) independently coded all included 
FCTC reports. Both authors independently identified many of 
the same codes, so consensus was reached quickly. Preliminary 
themes were shared with all authors to assist in the validation 
process. No substantive changes were recommended. This 
approach was well suited to the broad and sometimes inconsis-
tent scope and terminology of reporting across Australia, Canada 
and New Zealand. Content analysis was applied to capture 
and synthesise the diverse evidence, identifying and textually 
describing meaningful patterns and themes.26
ResulTs
Indigenous data, including any disparities in commercial 
tobacco use
The results are reported by: (1) Global Progress Reports, and (2) 
Country specific reports: Australia, Canada and New Zealand.
Global Progress Reports results
Seven Global Progress Reports from 2007 to 2016 were 
searched. Search terms were identified in the 2010, 2012 and 
2014 Global Reports (table 1).
Country reports: Australia, Canada and New Zealand
The information reported by Australia, Canada and New 
Zealand was diverse, although each country was relatively 
consistent in their respective reporting over time. Using content 
analysis, the following themes emerged: (1) smoking prevalence, 
(2) commentary on targets and strategies that were expected 
to impact indigenous commercial tobacco use, (3) descriptions 
of programmes, services and policies and (4) commentary on 
indigenous participation in the development and implement of 
commercial tobacco control activities (table 2). Australia consis-
tently provided details on prevalence and indigenous commercial 
tobacco reduction programmes and strategies; Canada detailed 
information regarding illicit or smuggled commercial tobacco; 
and New Zealand outlined Smoke-free Environments Regula-
tions 2007, including Māori language health warning and the 
goal of ‘reducing smoking prevalence and commercial tobacco 
availability to minimal levels by 2025’.
Smoking prevalence
Australia and New Zealand consistently reported smoking prev-
alence (table 3). Canada did not report prevalence of commer-
cial tobacco use among First Nations (status or non-status),27 
Inuit or Métis populations.
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Table 2 indigenous reporting themes in country-specific reports of 
Australia, Canada and New Zealand
Indigenous-specific references: Australia Canada
new 
Zealand
2007
  Prevalence ☑ ☑
  Targets, aims or objectives
  Programme and policy descriptions ☑
  Illicit trade ☑
  Taxation ☑
2009
  Prevalence ☑ ☑
  Targets, aims or objectives
  Programme and policy description/s ☑
  Illicit trade ☑
  Taxation
2012
  Prevalence ☑ ☑
  Targets, aims or objectives ☑
  Programme and policy description/s ☑ ☑ ☑
  Illicit trade ☑
  Taxation
2014
  Prevalence ☑ ☑
  Targets, aims or objectives ☑ ☑
  Programme and policy description/s ☑
  Illicit trade ☑
  Taxation
2016
  Prevalence ☑ ☑
  Targets, aims or objectives ☑ ☑
  Programme and policy description/s ☑
  Illicit trade ☑
  Taxation
Table 3 Reported indigenous smoking prevalence: Australia, Canada 
and New Zealand
Australia
(15 years and over) Canada new Zealand
2007 Aboriginal and Torres 
Strait Islander people:
Daily use: 50%.
Occasional use: 2%.
Not reported in 
FCTC reports.
Māori (2006):
Daily use: 43%.
Occasional use: 2%.
2009 Aboriginal and Torres 
Strait Islander people:
Total: 47%.
Not reported in 
FCTC reports.
Māori:
Daily use
Male: 40.4%.
Female: 49.7%.
Total: 45.4%.
2012 Aboriginal and Torres 
Strait Islander people:
Total: 47%.
Not reported in 
FCTC reports.
Māori:
Daily use
Male: 40.2%.
Female: 49.3%.
Total: 45.1%.
2014 Aboriginal and Torres 
Strait Islander people:
Male: 44.6%.
Female: 41.4%.
Total: 43%.
Not reported in 
FCTC reports.
Māori:
Daily use
Male: 36.4%.
Female: 41.8%.
Total: 39.2%.
2016 Aboriginal and Torres 
Strait Islander people:
Male: 44.6%.
Female: 41.4%.
Total: 43%.
Not reported in 
FCTC reports.
Māori:
Daily use
Male: 34.4%.
Female: 41.8%.
Total: 38.1%.
Indigenous participation
Only Australia explicitly referred to indigenous peoples partic-
ipating in the development and implementation of tobacco 
control interventions. The Tackling Indigenous Smoking 
measure, led by the National Coordinator Tackling Indig-
enous Smoking, was implemented and included a national 
network of Regional Tobacco Coordinators and Tobacco Action 
Workers. Workers were engaged through Aboriginal Commu-
nity Controlled Health Organisations where practicable to 
increase awareness of commercial tobacco harms and facilitate 
smoking prevention and cessation programmes. The network 
had access to funding and materials to conduct local commu-
nity-based social marketing campaigns and community events 
and the provision of training (2012, 2014 and 2016). Australian 
reports also referred to the Victorian State Best Practice Forum 
for Aboriginal Tobacco Control, which brought together stake-
holders to share their experiences and ideas on how to reduce 
tobacco-related harm (2016).
Canada and New Zealand made indirect references to indig-
enous peoples’ participation in tobacco control. In Canada, the 
reports referred to First Nations and Inuit Health and the Public 
Health Agency of Canada providing input into the development 
of the Federal Tobacco Control Strategy (2009, 2012, 2014 and 
2016). This strategy promoted smoking cessation among the 
First Nations, Inuit and Métis populations. In New Zealand 
reports, the Māori Affairs Select Committee inquiry into the 
harm caused to Māori by commercial tobacco was discussed. 
This committee included Māori members of Parliament and 
advisors who received submissions from individuals and organi-
sations, including those representing Māori interests.
Indigenous commercial tobacco reduction interventions 
under the FCTC
Targets, aims or objectives
Australia, Canada and New Zealand expressed commitments to 
reducing smoking prevalence among the respective indigenous 
populations. Australia and New Zealand described targets they 
were aiming to achieve, while Australia also described strategies 
to address commercial tobacco use among the indigenous popu-
lation. The Australian reports described the National Tobacco 
Strategy 2012–2018 that included an objective to halve the 
Aboriginal and Torres Strait Islander adult daily smoking rate 
by 2018, over the 2009 baseline (from 47%). The Strategy 
recognised the social and health inequalities associated with 
commercial tobacco use and emphasised the importance of 
working in partnership to reduce smoking rates among Aborig-
inal and Torres Strait Islander people (2014 and 2016). Reports 
from Canada referred to the Coordinated Effort to Effectively 
Address Tobacco Control in First Nations Communities and the 
Inuit Tobacco Reduction Strategy (2009, 2012, 2014 and 2016).
New Zealand described an official Parliament Māori Affairs 
Select Committee hearing that recommended 42 actions to 
reduce the harm caused by tobacco to Māori (2012). The 
Government generally accepted the recommendations, including 
the adoption of the goal that New Zealand should be ‘essentially’ 
smoke free by 2025 (2012). Interim targets were set, including 
halving the daily smoking prevalence among Māori by 2018, 
from their 2011–2012 levels (2014 and 2016).
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Programme, service and policy descriptions
Each country described to varying degrees programmes, services 
and policies to address commercial tobacco use among the respec-
tive indigenous populations. We identified commercial tobacco 
control interventions delivered as part of general population 
campaigns (with aspects prioritising indigenous populations) 
and programmes, services and policies designed specifically for 
indigenous peoples.
General population interventions
Types of general population interventions that included indige-
nous components and were common across at least two countries 
were: national and local mass communication/public awareness 
campaigns (Australia and Canada); commercial tobacco package 
health warnings (Australia and New Zealand); and reducing 
illicit trade (Canada and New Zealand). Australia consistently 
reported education, communication and public awareness 
campaigns being implemented at federal, state, territory, regional 
and local levels (2007, 2009, 2012, 2014 and 2016 reports). 
While Canada outlined partnerships between Health Canada 
and their First Nations and Inuit partners to reduce commer-
cial tobacco use, and a partnership with the Cancer Society to 
get young people talking about smoking, quitting and remaining 
smoke free (2009, 2012, 2014 and 2016). In relation to health 
warnings, New Zealand (2009, 2012 and 2014) made specific 
reference to the inclusion of Māori text (along with English) 
with new pictorial health warnings on tobacco packaging.
References to illicit trade in Canadian reports (2007, 2009, 
2012, 2014 and 2016) identified First Nations communities as 
sources of illicit commercial tobacco. The reports noted that 
a key source of illicit commercial tobacco was fully equipped 
industrial plants located in First Nations communities. Further-
more, manufacturing operations located on tribal lands in the 
USA were described as supplying the majority of the illicit 
market for commercial tobacco products (2007). The reports 
also described an increasing number of ‘Smoke Shacks’ on some 
First Nation reserve lands, which were designed for large volume 
cigarette sales and were seen as distributors for the underground 
market (2007). Canadian reports also detail a special unit of the 
Royal Canadian Mounted Police, the Anti-Contraband Tobacco 
Force, which was established to address illicit trade, along with 
a ‘Trafficking in Contraband Tobacco Act’ and funding for First 
Nations police services to target contraband commercial tobacco 
(2014 and 2016). New Zealand references to illicit trade and 
Māori were made in the context of commercial tobacco products 
in the New Zealand market requiring Māori language health 
warnings. This helped to determine if products were legal or 
illicit (2009, 2012 and 2014).
Australia reported on general population interventions that 
were seen as being effective for indigenous populations. These 
were the introduction of plain packaging (2012), enhancing 
Quitlines to be responsive to Aboriginal and Torres Strait 
Islander needs (2012, 2014 and 2016) and implementing Nico-
tine Replacement Therapy interventions (2007, 2012 and 2016) 
for eligible Aboriginal and Torres Strait Islander peoples (2012).
Indigenous-specific interventions
Only Australia and Canada described indigenous-specific policy 
and programmes. Both countries commented on the develop-
ment of cessation services for indigenous populations. The 
Australian reports described smoking cessation resources and 
training (eg, brief intervention training) that were developed 
and implemented for people working with Aboriginal and Torres 
Strait Islander peoples, including Aboriginal Health Workers 
(2007, 2009, 2012, 2014 and 2016) and a smoking cessation 
programme for Aboriginal mothers (2009).
In addition, Australian reports described comprehensive 
public health packages to address Aboriginal and Torres Strait 
Islander smoking (2012, 2014 and 2016) and an Indigenous 
Tobacco Control Initiative, which piloted innovative approaches 
to reduce smoking (2012).
DIsCussIon
The FCTC continues to influence the global tobacco control 
agenda and has the potential to drive action. Improved FCTC 
reporting would enable Parties to better recognise their account-
ability due to increased transparency. The FCTC obligates 
parties to implement measures that reduce tobacco harm within 
their respective countries and collectively, working against the 
tobacco epidemic at a global level. Reducing the dispropor-
tionate tobacco-related harm among indigenous peoples is also 
implied in the FCTC Preamble and an important requirement 
of those countries with colonial histories.2 For the countries 
included in this analysis, we found marked variation in how they 
have reported progress to address tobacco-related harms among 
indigenous peoples.
Our first aim was to explore whether indigenous data were 
being reported, including any disparities in commercial tobacco 
use between indigenous and non-indigenous peoples. Overall, 
this assessment found variation in how Australia, Canada and 
New Zealand reported progress to address tobacco-related 
harms among indigenous peoples. We found inconsistent use 
of terminology and measures across the three countries. For 
example, the term ‘ethnic’ was sometimes applied to peoples of 
non-European descent, in general, and at other times specifically 
to indigenous populations. This limits the ability to identify, 
compare and share achievements and challenges of indigenous 
peoples, as well as accurately measure changes in commercial 
tobacco use or highlight any disparities. Furthermore, only 
Australia and New Zealand reported smoking prevalence within 
the respective indigenous populations. These countries reported 
decreasing trends in indigenous smoking prevalence respectively 
(Australia and New Zealand 2007, 2009, 2012, 2014 and 2016). 
However, smoking prevalence remained alarmingly high and at 
least double the rate of the respective non-indigenous popula-
tions (Australia and New Zealand 2007, 2009, 2012, 2014 and 
2016). Collecting and reporting these data are an essential means 
of monitoring success (or otherwise) in reducing smoking dispar-
ities and the overall progress towards FCTC goals. Furthermore, 
there were no references to indigenous peoples in any of the 
Global Progress Reports over the first three reporting periods. 
This is a missed opportunity to create international reporting of 
indigenous baseline data and context-specific factors critical to 
the tobacco control landscape such as indigenous-focused inter-
ventions. As a result, indigenous peoples have been relatively 
‘invisible’ in terms of limited monitoring and having the ability 
to compare factors over time. However, Australia and New 
Zealand have long-standing, relatively high-quality monitoring 
systems (while acknowledging limitations, such as indigenous 
identifier misclassification and sampling bias) that include data 
on indigenous tobacco use.
Our second aim sought to determine the extent to which 
indigenous peoples were reported to be participating in the 
development, implementation and evaluation of tobacco control 
initiatives. Indigenous engagement will help develop owner-
ship over interventions and assists to ensure conception and 
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implementation in an appropriate and effective manner. Two 
notable participatory mechanisms were the Tackling Indigenous 
Smoking programme in Australia. This programme sought feder-
al-level, state-level and local-level planning and coordination of 
tobacco control activity for and with Aboriginal and Torres Strait 
Islander peoples. A second mechanism was the Māori Affairs 
Select Committee inquiry in New Zealand on the impact of 
smoking on Māori. All three countries included some comment 
on indigenous participation within the planning and delivery of 
their respective tobacco control programmes. However, partic-
ipation tended to be described in relation to specific aspects 
(such as cessation services), and it was not clear when describing 
the extent of indigenous participation throughout a country’s 
tobacco control programme. It would be useful to report on 
indigenous engagement in legislative interventions that affect the 
entirety of the population and have the potential for equitable 
impacts across subpopulations. For example, whether indig-
enous peoples participated in the development of tobacco tax 
regimes or the introduction of standardised packaging.
Our final aim was to examine if indigenous-focused inter-
ventions to reduce the use of commercial tobacco products 
were being delivered and evaluated. No evaluative information 
was provided in FCTC reports regarding actual or potential 
impacts of general or indigenous specific tobacco reduction 
interventions. Without such information, it is not possible to 
assess whether interventions were having direct or indirect 
impacts on indigenous smoking prevalence, and there are 
limited opportunities for other countries to learn from their 
experiences.
Data on indigenous interventions was available, for example, 
Minichiello et al’s reported effective strategies to reduce commer-
cial tobacco use in indigenous communities.4 The review identi-
fied 42 interventions in Australia (n=19), Canada (n=14), New 
Zealand (n=8) andAustralia and New Zealand (n=1) published 
between 2005 and 20154 that aimed to prevent, reduce and/
or cease the use of commercial tobacco use among indigenous 
peoples. Given the availability of data, this information could 
be more fully captured by more appropriate FCTC reporting 
instruments, providing opportunities to share and learn from 
tobacco control experiences.
Another omission from the FCTC reports was the prevalence 
of commercial tobacco use among First Nations, Inuit and Métis 
peoples. Canada is generally known for excellence in quality 
and relevance of its health statistics.14 However, as Smylie and 
Firestone14 demonstrated, indigenous data quality issues such 
as non-response and bias misclassification errors contribute to 
significantly underestimating health inequities between indige-
nous and non-indigenous peoples. While acknowledging these 
data quality limitations,14 we also note that the prevalence of 
commercial tobacco use among First Nations, Inuit and Métis 
peoples have been reported elsewhere.12 Therefore, and as 
outlined in the limitations, care should be taken when consid-
ering these findings as the FCTC reporting may not accurately 
capture and reflect what is actually happening in relation 
to tobacco control among to indigenous peoples under the 
FCTC. We also note that this may reflect some complexity and 
dynamic nature of indigenous tobacco control and the discon-
nect between reporting agencies and their respective indigenous 
tobacco control communities.
Australia, Canada and New Zealand have expressed commit-
ments to reducing the use of commercial tobacco products 
among indigenous populations; however, only Australia and 
New Zealand commented on specific smoking targets. Canadian 
reports commented on the development of a First Nations and 
Inuit Tobacco Control Strategy in 2006,28 29 although it appears 
this strategy has not eventuated.
All three countries also described general population inter-
ventions that were expected to impact indigenous commercial 
tobacco use. Types of general population interventions that were 
expected to make a significant impact on indigenous smoking 
varied across the countries. At least two described mass commu-
nications campaigns delivered at national and/or local levels 
(Australia and Canada), health warnings (Australia and New 
Zealand) and illicit trade (Canada and New Zealand). However, 
the commentary around illicit trade within Canada was unique, 
identifying this as a ‘problem’ within indigenous communi-
ties, highlighting the inclination to ‘problematise’ indigenous 
peoples. Only two countries (Australia and Canada) described 
indigenous specific interventions, and these mainly focused on 
the development and delivery of cessation services.
While some progress has been made, there is significant scope 
for improving how country and global reports share FCTC prog-
ress towards reducing commercial tobacco use among indige-
nous peoples. Opportunities for improving reporting include: 
improving consistent use of definitions and measures; reporting 
on how indigenous peoples are participating throughout tobacco 
programmes and policies; and supporting the evaluation of indige-
nous specific and general population tobacco control interventions 
with a focus on effectiveness and smoking prevalence. There are 
at least two inter-related mechanisms through which these oppor-
tunities could be realised: (1) the WHO could provide leadership 
on FCTC Parties reporting in relation to indigenous commercial 
tobacco use and (2) Parties could use indigenous leadership and 
expertise in relation to wise practices in working with indigenous 
peoples in tobacco control.
In relation to the first mechanism, a key issue is inherent within 
the reporting templates provided for the ‘Core’ and ‘Additional 
Questions’. There are currently no specific expectations for Parties 
to report on commercial tobacco use among theindigenous popu-
lations. This is likely to have contributed to the inconsistent and 
probable under-reporting regarding tobacco control and indige-
nous peoples. For example, the Core Instrument Section 2.1.5 asks 
countries to report smoking rates within various subpopulations, 
including ethnic groups.5 However, the definition of ‘ethnic’ is 
ambiguous, and indigenous peoples are treated in a similar manner 
to other ‘ethnic’ groups.5 There are also questions in the instru-
ment about whether legislation has been passed that bans smoking 
in indoor workplaces, public transport and public spaces (section 
3.2.2).5 A follow-up question asks whether this legislation has been 
implemented in ‘cultural facilities’. In the template, there are no 
opportunities to distinguish whether these facilities are associ-
ated with indigenous peoples and ethnic groups or to describe the 
respective community engagement in the development of the legis-
lation.5 29 Section 3.2.6 explores whether a Party has implemented 
educational and public awareness tobacco control programmes. 
This includes prompts to elicit whether ethnic groups are targeted 
by these programmes or if cultural differences were taken into 
account.5 However, the ethnic groups targeted or the cultural 
differences acknowledged cannot be indicated within the template. 
Questions also seek to establish what types of agencies and non-gov-
ernment organisations were involved in the ‘… development and 
implementation of intersectoral programmes and strategies for 
tobacco control’. Furthermore, an ‘other (please specify)’ category 
is offered for organisations not listed, but there is no specific refer-
ence to indigenous engagement or any indigenous prompt.5
Supporting indigenous engagement in tobacco control activity 
is specifically referenced in the FCTC, under Article 4 of the 
Guiding Principles. As a Guiding Principle, it would be expected 
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What this paper adds
What is already known on this subject
 ► Indigenous populations in Australia, Canada and New 
Zealand have disproportionately high rates of commercial 
tobacco use compared with their non-indigenous 
counterparts.
 ► Australia, Canada and New Zealand are States Parties to the 
WHO Framework Convention on Tobacco Control (FCTC) and 
are thus committed to addressing the particular needs and 
challenges experienced by indigenous peoples in reducing 
commercial tobacco use. The FCTC highlights the importance 
of facilitating indigenous leadership and participation in 
developing, implementing and evaluating socially and 
culturally appropriate commercial tobacco reduction 
interventions.
 ► Systematic reviews suggest evidence of a growing 
prioritisation and readiness to address the high rates of 
commercial tobacco use within Australia, Canada and New 
Zealand. Supporting such actions, and measuring progress, 
requires improvements in the FCTC reporting systems on 
actions to reduce indigenous commercial tobacco use.
What important gaps in knowledge exist on this topic
 ► There are gaps in reporting and sharing knowledge about 
commercial tobacco use among indigenous peoples and how 
commercial tobacco use can be reduced. Addressing these 
gaps in reporting and sharing knowledge about commercial 
tobacco use will help inform the reduction of smoking 
disparities between indigenous and non-indigenous peoples.
 ► There is limited evidence in relation to the extent of reporting 
and sharing knowledge about commercial tobacco use 
among indigenous peoples via FCTC reporting mechanisms.
What this paper adds
 ► Existing gaps in FCTC reporting make it difficult to determine 
if or what progress has been made within States Parties 
and comparably across countries. This review points to 
the need for more detailed and standardised reporting on 
FCTC progress in achieving FCTC commitments to reducing 
commercial tobacco use among indigenous peoples.
 ► Strengthening FCTC reporting instruments to include 
indigenous-specific data will help to realise the FCTC Guiding 
Principles, building the evidence base and momentum to 
improve tobacco control and reduce commercial tobacco use 
among indigenous peoples.
that all Articles of the FCTC are relevant for indigenous peoples. 
To this end, additional fields could be added to the ‘Additional 
Questions’ template that sit alongside the existing Core template 
questions that elicit information and explore relevant topics 
including: indigenous exposure to secondhand smoke; tobacco 
related mortality; the economic burden on indigenous peoples 
due to commercial tobacco use; whether indigenous peoples 
are participating in the development of legislation; whether 
health warnings are relevant to indigenous peoples, if cessation 
programmes are tailored for indigenous peoples; and if research, 
surveillance and exchange of information are relevant to indige-
nous peoples.
Discussion and agreement among relevant Parties regarding an 
appropriate indigenous reporting framework needs to occur to 
ensure that any additional reporting fields are relevant, practical 
and ultimately assist to reduce tobacco harm among indigenous 
peoples. To this end, an indigenous expert working group or estab-
lishment of indigenous collaborating centres for reducing commer-
cial tobacco use could be established to help develop and review 
potential options for such a framework and relevant indicators.
The second mechanism for improving FCTC reporting could 
include Parties ensuring indigenous peoples are encouraged, 
engaged and supported, incorporating financial support to take 
domestic and international collaborative action. It is expected 
that this action would help improve and set standards for what is 
reported (eg, ethical ways of engaging with indigenous peoples). 
Furthermore, collaborative action could help establish consis-
tent use (or recognise where differences are important) for terms 
and measures (eg, common and appropriate definitions for 
ethnicity and specific indigenous indicators, prompts and data 
collection methods) that will ultimately lead to better reporting. 
This action could be realised through relevant parties including 
indigenous-related data in their country reports, as well as 
advocating to the WHO to update the reporting templates and 
promoting to member countries why these updates are central 
to reducing indigenous commercial tobacco use. In the case of 
improving the extent of indigenous tobacco prevalence data, 
many countries collect high-quality data for these groups (eg, the 
National Aboriginal and Torres Strait Islander Health and Social 
Surveys in Australia, and the New Zealand Health Survey). In 
addition, these countries could also identify opportunities for 
improving their monitoring, surveillance and intervention eval-
uation systems that would help reporting. This would include 
wise practices for engaging indigenous peoples around research, 
recognition of achievements and innovative approaches, surveil-
lance and evaluation and whether data are comparable, or how 
comparable data could be produced.
strengths and limitations
Strengths of this study were that indigenous peoples from 
Oceania and North America led and participated in all stages 
of the study process. This included formulating study aims, 
methods, analysis and interpreting results. As such, this research 
reflects a uniquely indigenous perspective on the quality of 
reporting. However, the authors recognise that perspectives 
from indigenous peoples outside of the scope of this project may 
not have been covered (such as South America or other parts of 
the Pacific). Further studies should be undertaken that include 
a broader range of countries with indigenous populations and 
directly engage indigenous peoples.
The study focused on what was reported in the global and 
country specific reports. Therefore, care should be taken when 
considering the findings, as the reports may not accurately reflect 
what is actually happening under the FCTC or in the respective 
countries.
ConClusIon
Recognition of commercial tobacco harms and the need to 
partner with indigenous peoples to take action as part of FCTC 
commitments are essential steps towards improving indigenous 
health and reducing health inequities. As a result, FCTC Parties 
that have indigenous populations should incorporate compre-
hensive and high-quality standardised indigenous-specific data in 
their regular reporting to assist in reducing tobacco harms among 
indigenous peoples. Such improvement in reporting would align 
with the intent of the FCTC, including assisting to reaffirm the 
right of all people to the highest standard of health.2 12 Within 
the FCTC reports, we found significant gaps in what was being 
reported and, in many instances, it was difficult to determine 
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if or what, if any, progress was being made under the FCTC. 
However, we identified some evidence that progress was being 
made towards reducing tobacco-related harm among indigenous 
peoples. This included the implementation of indigenous-fo-
cused initiatives and evidence of declining tobacco prevalence. 
Strengthening reporting instruments to include indigenous 
data is essential to realising the Guiding Principles and to close 
the gaps between indigenous and non-indigenous commer-
cial tobacco use, increasing Parties’ accountability, particularly 
to indigenous peoples and through their obligations as WHO 
Members via increased reporting and transparency. This would 
align indigenous reporting with other specific populations iden-
tified within the FCTC reporting instruments, such as women, 
youth and children.
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